STI Stock Trade Intelligence
HPC

THE HYDRATION PHARMACEUTICALS COMPANY LIMITED

Consumer Staples · ASX:HPC
$0.0020
0.00%
Market cap
$1M
Turnover
—
Last price
$0.0020
Day change
0.00%
Announcements
13
Range, past year
Open 0.006 · Low 0.002 · Now 0.002 · High 0.019
Open HPC in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.

HPC momentum and trend analysis

Our analysis
Independent analysis generated by Stock Trade Intelligence as at 2026-11-16.
Momentum quality
27/100
Wyckoff phase
Accumulation15d
Trend stage
Breakdown
1 Day
+0.0%
1 Week
-33.3%
1 Month
-33.3%
1 Year
-66.7%
RSI
41
Avg daily range
19.4%

THE HYDRATION PHARMACEUTICALS COMPANY LIMITED scores 27 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Breakdown.

On the Wyckoff cycle it sits in Accumulation, where it has been for 15 trading days. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.

Against the wider market it is currently underperforming and the institutional accumulation signal reads low.

What stands out
  • Volume 2.2× 60-day avg
Points to watch
  • 60d drawdown -50.0%
  • High volatility (ATR 19.4%)
  • Risk rating: Very High
  • Composite downside risk elevated
HPC appears on this screen:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highs

HPC announcements

Recent price-sensitive releases.
  • 2026-11-11 Investor Presentation Company Presentation
  • 2026-10-30 Q3 FY26 Quarterly Activities Report (App 4C) Commitments Test Entity - Third Quarter Activity Report | Commitments Test Entity - Third Quarter Cashflow Report
  • 2026-10-23 Prospectus - Non Renounceable Rights Issue Non-Renounceable Issue | Disclosure Document
  • 2026-10-23 Rights Issue and UMP Share Sale Facility Non-Renounceable Issue | Issued Capital - Other
  • 2026-09-29 July and August 2026 Trading Update Trading Update
  • 2026-08-31 Appendix 4D and FY26 Half Year Financial Report Half Yearly Report | Half Year Audit Review | Half Year Directors' Statement | Half Year Accounts | Half Year Directors' Report
  • 2026-07-31 Q2 FY26 Quarterly Activities Report (App 4C) Commitments Test Entity - Second Quarter Activity Report | Commitments Test Entity - Second Quarter Cashflow Report
Get the daily briefing The day's price-sensitive announcements, ranked by what actually moved, with our own momentum and cycle read on each.